29 completed. 29 Phase 3, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 29 | Completed 29 |
| Phase 2 | 5 | Completed 5 |
Follow Obstructive Sleep Apnea: new trials by email Literature Review of Obstructive Sleep Apnea trials Research Report on Obstructive Sleep Apnea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA IHL-42X Low Dose, IHL-42X High Dose, Placebo - Obstructive Sleep Apnea | Phase 2 / Phase 3 | Completed | Incannex Healthcare Ltd | 121 | 2024-05-02 | 2026-07-27 |
| A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight Retatrutide, Placebo - Type 2 Diabetes, Obesity | Phase 3 | Completed | Eli Lilly and Company | 1152 | 2023-07-11 | 2026-07-30 |
| A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight Retatrutide, Placebo - Obesity, Overweight | Phase 3 | Completed | Eli Lilly and Company | 2335 | 2023-07-10 | 2026-08-21 |
| Dexamethasone Treatment for OSA in Children Dexamethasone, Placebo Control - Obstructive Sleep Apnea | Phase 3 | Completed | The Hospital for Sick Children | 10 | 2022-10-26 | 2026-05-12 |
| Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea Tirzepatide, Placebo - Obstructive Sleep Apnea, Obesity | Phase 3 | Completed | Eli Lilly and Company | 469 | 2022-06-21 | 2025-04-30 |
| Vitamin D and SGLT-2 Inhibitor in CPAP-naive Obstructive Sleep Apnea Dapagliflozin (Forxiga), Vitamin D3 ( Colecalciferol), Vitamin D3 plus Dapagliflozin - Obstructive Sleep Apnea | Phase 3 | Completed | University Malaysia Sarawak | 160 | 2022-06-08 | 2024-11-15 |
| Pitolisant (BF2.649) in the Treatment of EDS in Patients With OSA Pitolisant (BF2.649), Placebo - Excessive Daytime Sleepiness, Obstructive Sleep Apnea | Phase 3 | Completed | Bioprojet | 389 | 2016-04-01 | 2020-07-08 |
| "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" JZP-110, Placebo oral tablet - Obstructive Sleep Apnea | Phase 3 | Completed | Jazz Pharmaceuticals | 476 | 2015-05-01 | 2019-07-23 |
| "Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" JZP-110 - Obstructive Sleep Apnea | Phase 3 | Completed | Jazz Pharmaceuticals | 174 | 2015-05-01 | 2019-09-09 |
| "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA" JZP-110 - Narcolepsy, Obstructive Sleep Apnea | Phase 3 | Completed | Jazz Pharmaceuticals | 645 | 2015-05-01 | 2019-06-25 |
| Effect of Antihypertensive Agents Over Sleep Apnea Diuretics, Calcium Channel Blockers - Hypertension, Obstructive Sleep Apnea | Phase 3 | Completed | Hospital de Clinicas de Porto Alegre | 53 | 2014-12-01 | 2016-07-14 |
| BF2.649 in Patients With OSA, Still Complaining of EDS and Refusing to be Treated by CPAP. BF2.649, Placebo - Obstructive Sleep Apnea, Excessive Daytime Sleepiness | Phase 3 | Completed | Bioprojet | 268 | 2011-10-01 | 2015-01-21 |
| BF2.649 in Patients With OSA and Treated by CPAP But Still Complaining of EDS BF2.649, Placebo - Obstructive Sleep Apnea, Excessive Daytime Sleepiness | Phase 3 | Completed | Bioprojet | 244 | 2011-08-01 | 2015-01-21 |
| Effect of Zopiclone on Compliance With Continuous Positive Airway Pressure in Obstructive Sleep Apnea Placebo, Zopiclone - Obstructive Sleep Apnea | Phase 3 | Completed | OSR Medical Inc. | 264 | 2011-05-01 | 2015-07-17 |
| Montelukast and Inhaled Nasal Steroid Tx in Adult Obstructive Sleep Apnea (OSA) budesonide and montelukast, Placebo - Obstructive Sleep Apnea | Phase 3 | Completed | Romaker & Associates | 34 | 2010-09-01 | 2018-12-03 |
| Stimulation Therapy for Apnea Reduction (Www.theSTARtrial.Com) Inspire Upper Airway Stimulation System - Obstructive Sleep Apnea | Phase 3 | Completed | Inspire Medical Systems, Inc. | 929 | 2010-07-01 | 2017-08-25 |
| US Clinical Study of the Apnex Medical Hypoglossal Nerve Stimulation (HGNS) System to Treat Obstructive Sleep Apnea HGNS Treatment - Obstructive Sleep Apnea | Phase 2 / Phase 3 | Completed | Apnex Medical, Inc. | 20 | 2010-07-01 | 2015-04-15 |
| Australian Clinical Study of the Apnex Medical HGNS System to Treat Obstructive Sleep Apnea HGNS Treatment - Obstructive Sleep Apnea | Phase 2 / Phase 3 | Completed | Apnex Medical, Inc. | 40 | 2009-03-01 | 2015-04-15 |
| Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA) - Obstructive Sleep Apnea, Stroke | Phase 2 / Phase 3 | Completed | VA Office of Research and Development | 225 | 2008-12-23 | 2017-06-14 |
| Effects of Continuous Positive Airway Pressure (CPAP) in Patients With Resistant Hypertension and Obstructive Sleep Apnea (OSA) CPAP - Obstructive Sleep Apnea, Refractory Hypertension | Phase 3 | Completed | University of Sao Paulo | 40 | 2008-10-01 | 2011-11-23 |
Showing 20 of 29. Sign in to see all of them.
Sleep Apnea, Obstructive (29) · Sleep Apnea Syndromes (6) · Disorders of Excessive Somnolence (5) · Hypertension (4) · Obesity (3) · Overweight (2) · Brain Ischemia (1) · Communication Disorders (1) · Diabetes Mellitus, Type 2 (1) · Ischemic Attack, Transient (1) · Narcolepsy (1) · Nasal Obstruction (1) · Osteoarthritis, Knee (1) · Sleep Initiation and Maintenance Disorders (1) · Sleep Wake Disorders (1)
Apnea (29) · Dyssomnias (29) · Nervous System Diseases (29) · Respiration Disorders (29) · Respiratory Tract Diseases (29) · Sleep Disorders, Intrinsic (29) · Sleep Wake Disorders (28) · Sleep Apnea Syndromes (23) · Mental Disorders (8) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Cardiovascular Diseases (4) · Vascular Diseases (4) · Body Weight (3) · Nutrition Disorders (3)
pitolisant (3) · solriamfetol (3) · Modafinil (2) · retatrutide (2) · Acetazolamide (1) · Amiloride (1) · Amlodipine (1) · Budesonide (1) · Calcium Channel Blockers (1) · Chlorthalidone (1) · Cholecalciferol (1) · Dexamethasone (1) · Dexmedetomidine (1) · Diuretics (1) · Dronabinol (1)
Bioprojet (3) · Eli Lilly and Company (3) · Jazz Pharmaceuticals (3) · Apnex Medical, Inc. (2) · Cephalon (2) · Clayton Sleep Insititute (2) · University of Sao Paulo (2) · Hospital de Clinicas de Porto Alegre (1) · Incannex Healthcare Ltd (1) · Inspire Medical Systems, Inc. (1) · Nykøbing Falster County Hospital (1) · OSR Medical Inc. (1) · Romaker & Associates (1) · Stanford University (1) · The Hospital for Sick Children (1)
United States (16) · Brazil (6) · France (6) · Canada (5) · Germany (5) · Australia (3) · Mexico (3) · Netherlands (3) · Finland (2) · India (2) · Puerto Rico (2) · Romania (2) · Spain (2) · Argentina (1) · Belgium (1)
Evelyne De Paillette, MD (2) · Ann Romaker, MD (1) · Anuradha Patel, MD (1) · Barbara Capozzolo, MSc (1) · Clete A. Kushida M.D., Ph.D. (1) · Con Iber, MD (1) · David Hillman, MD (1) · Dawn M. Bravata, MD (1) · Doug McEvoy, MD (1) · Eric Kezirian, MD (1) · Eric Powell, PhD (1) · Fabio T Cichelero, MD (1) · Flavio D Fuchs, MD, PhD (1)
PMID 37979718, PMID 19234106, PMID 21885958, PMID 22043118, PMID 22334806, PMID 22334808, PMID 22968110, PMID 23598607, PMID 24382030, PMID 24401051, PMID 24458967, PMID 30471270, PMID 30521757, PMID 31383235, PMID 31691827, PMID 31917607, PMID 32353246, PMID 32970962, PMID 33121980, PMID 33179591, PMID 33226332, PMID 33295277, PMID 33394323, PMID 33631141, PMID 33647987, PMID 34283019, PMID 34606437, PMID 36084494, PMID 38547961, PMID 38781664, PMID 38912654, PMID 40055713, PMID 40774158, PMID 41135142, PMID 41540105, PMID 41793578, PMID 42166156, PMID 42412744, PMID 42675225, PMID 42774617, PMID 42810372, PMID 42814954
2023 (2), 2009 (1)